Jennison Associates’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-30,119
| Closed | -$767K | – | 582 |
|
|
2024
Q3 | $767K | Buy |
+30,119
| New | +$767K | ﹤0.01% | 510 |
|
|
2024
Q1 | – | Sell |
-19,357
| Closed | -$781K | – | 578 |
|
|
2023
Q4 | $781K | Sell |
19,357
-944
| -5% | -$38.1K | ﹤0.01% | 519 |
|
|
2023
Q3 | $535K | Sell |
20,301
-33,589
| -62% | -$886K | ﹤0.01% | 536 |
|
|
2023
Q2 | $927K | Buy |
53,890
+13,666
| +34% | +$235K | ﹤0.01% | 497 |
|
|
2023
Q1 | $667K | Sell |
40,224
-58,730
| -59% | -$974K | ﹤0.01% | 544 |
|
|
2022
Q4 | $754K | Buy |
98,954
+12,048
| +14% | +$91.8K | ﹤0.01% | 532 |
|
|
2022
Q3 | $864K | Buy |
+86,906
| New | +$864K | ﹤0.01% | 519 |
|